(Q53900094)

22 May 2018

title

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. (English)

1 reference

22 May 2018

main subject

visceral leishmaniasis

1 reference

1 reference

Thakur CP

1

1 reference

22 May 2018

Kanyok TP

2

1 reference

22 May 2018

Pandey AK

3

1 reference

22 May 2018

Sinha GP

4

1 reference

22 May 2018

Messick C

5

1 reference

22 May 2018

Olliaro P

6

1 reference

22 May 2018

publication date

1 July 2000

1 reference

22 May 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

22 May 2018

volume

94

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

432-433

1 reference

22 May 2018

Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990131-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0035-9203(00)90131-7

1 reference

22 May 2018

1 reference

22 May 2018